Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Interleukin-22 Might Act as a Double-Edged Sword in Type 2 Diabetes and Coronary Artery Disease.

Gong F, Wu J, Zhou P, Zhang M, Liu J, Liu Y, Lu X, Liu Z.

Mediators Inflamm. 2016;2016:8254797.

2.

The Roles of CD137 Signaling in Atherosclerosis.

Jung IH, Oh GT.

Korean Circ J. 2016 Nov;46(6):753-761. Review.

3.

Inhibition of RORα/γ suppresses atherosclerosis via inhibition of both cholesterol absorption and inflammation.

Billon C, Sitaula S, Burris TP.

Mol Metab. 2016 Jul 25;5(10):997-1005. doi: 10.1016/j.molmet.2016.07.001.

4.

Aortic VCAM-1: an early marker of vascular inflammation in collagen-induced arthritis.

Denys A, Clavel G, Lemeiter D, Schischmanoff O, Boissier MC, Semerano L.

J Cell Mol Med. 2016 May;20(5):855-63. doi: 10.1111/jcmm.12790.

5.

CXCR6 regulates the recruitment of pro-inflammatory IL-17A-producing T cells into atherosclerotic aortas.

Butcher MJ, Wu CI, Waseem T, Galkina EV.

Int Immunol. 2016 May;28(5):255-61. doi: 10.1093/intimm/dxv068.

PMID:
26614640
6.

Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance.

Palmer DC, Guittard GC, Franco Z, Crompton JG, Eil RL, Patel SJ, Ji Y, Van Panhuys N, Klebanoff CA, Sukumar M, Clever D, Chichura A, Roychoudhuri R, Varma R, Wang E, Gattinoni L, Marincola FM, Balagopalan L, Samelson LE, Restifo NP.

J Exp Med. 2015 Nov 16;212(12):2095-113. doi: 10.1084/jem.20150304.

7.

Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.

Mohamed R, Jayakumar C, Chen F, Fulton D, Stepp D, Gansevoort RT, Ramesh G.

J Am Soc Nephrol. 2016 Mar;27(3):745-65. doi: 10.1681/ASN.2014111136.

PMID:
26334030
8.

Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets.

Ramji DP, Davies TS.

Cytokine Growth Factor Rev. 2015 Dec;26(6):673-85. doi: 10.1016/j.cytogfr.2015.04.003. Review.

9.

Infection and Atherosclerosis Development.

Campbell LA, Rosenfeld ME.

Arch Med Res. 2015 Jul;46(5):339-50. doi: 10.1016/j.arcmed.2015.05.006. Review.

10.

Human monocyte-derived dendritic cells turn into foamy dendritic cells with IL-17A.

Salvatore G, Bernoud-Hubac N, Bissay N, Debard C, Daira P, Meugnier E, Proamer F, Hanau D, Vidal H, Aricò M, Delprat C, Mahtouk K.

J Lipid Res. 2015 Jun;56(6):1110-22. doi: 10.1194/jlr.M054874.

11.

Reduced Atherosclerosis in apoE-inhibitory FcγRIIb-Deficient Mice Is Associated With Increased Anti-Inflammatory Responses by T Cells and Macrophages.

Ng HP, Zhu X, Harmon EY, Lennartz MR, Nagarajan S.

Arterioscler Thromb Vasc Biol. 2015 May;35(5):1101-12. doi: 10.1161/ATVBAHA.115.305290.

12.

Emerging translational approaches to target STAT3 signalling and its impact on vascular disease.

Dutzmann J, Daniel JM, Bauersachs J, Hilfiker-Kleiner D, Sedding DG.

Cardiovasc Res. 2015 Jun 1;106(3):365-74. doi: 10.1093/cvr/cvv103. Review.

13.

Interleukin 13- and interleukin 17A-induced pulmonary hypertension phenotype due to inhalation of antigen and fine particles from air pollution.

Park SH, Chen WC, Esmaeil N, Lucas B, Marsh LM, Reibman J, Grunig G.

Pulm Circ. 2014 Dec;4(4):654-68. doi: 10.1086/678511.

14.

Autophagic marker MAP1LC3B expression levels are associated with carotid atherosclerosis symptomatology.

Swaminathan B, Goikuria H, Vega R, Rodríguez-Antigüedad A, López Medina A, Freijo Mdel M, Vandenbroeck K, Alloza I.

PLoS One. 2014 Dec 12;9(12):e115176. doi: 10.1371/journal.pone.0115176.

15.

T cells in vascular inflammatory diseases.

Lintermans LL, Stegeman CA, Heeringa P, Abdulahad WH.

Front Immunol. 2014 Oct 14;5:504. doi: 10.3389/fimmu.2014.00504. Review.

16.

The role of T and B cells in human atherosclerosis and atherothrombosis.

Ammirati E, Moroni F, Magnoni M, Camici PG.

Clin Exp Immunol. 2015 Feb;179(2):173-87. doi: 10.1111/cei.12477. Review.

17.

Lymphocyte migration into atherosclerotic plaque.

Li J, Ley K.

Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):40-9. doi: 10.1161/ATVBAHA.114.303227. Review.

18.

IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis.

Erbel C, Akhavanpoor M, Okuyucu D, Wangler S, Dietz A, Zhao L, Stellos K, Little KM, Lasitschka F, Doesch A, Hakimi M, Dengler TJ, Giese T, Blessing E, Katus HA, Gleissner CA.

J Immunol. 2014 Nov 1;193(9):4344-55. doi: 10.4049/jimmunol.1400181.

19.

B2 cells suppress experimental abdominal aortic aneurysms.

Meher AK, Johnston WF, Lu G, Pope NH, Bhamidipati CM, Harmon DB, Su G, Zhao Y, McNamara CA, Upchurch GR Jr, Ailawadi G.

Am J Pathol. 2014 Nov;184(11):3130-41. doi: 10.1016/j.ajpath.2014.07.006.

20.

Dysregulation of the suppressor of cytokine signalling 3-signal transducer and activator of transcription-3 pathway in the aetiopathogenesis of Sjögren's syndrome.

Vartoukian SR, Tilakaratne WM, Seoudi N, Bombardieri M, Bergmeier L, Tappuni AR, Fortune F.

Clin Exp Immunol. 2014 Sep;177(3):618-29. doi: 10.1111/cei.12377.

Items per page

Supplemental Content

Support Center